Pancreatic Stone Protein: Review of a New Biomarker in Sepsis

Research output: Contribution to journalReview articlepeer-review

12 Citations (Scopus)
23 Downloads (Pure)


Sepsis is a life-threatening syndrome characterized by a dysregulated host response to an infection that may evolve rapidly into septic shock and multiple organ failure. Management of sepsis relies on the early recognition and diagnosis of infection and the providing of adequate and prompt antibiotic therapy and organ support. A novel protein biomarker, the pancreatic stone protein (PSP), has recently been studied as a biomarker of sepsis and the available evidence suggests that it has a higher diagnostic performance for the identification of infection than the most used available biomarkers and adds prognostic value. This review summarizes the clinical evidence available for PSP in the diagnosis and prognosis of sepsis.

Original languageEnglish
Article number1085
JournalJournal of Clinical Medicine
Issue number4
Publication statusPublished - 1 Feb 2022


  • Biomarker
  • Infection
  • Pancreatic stone protein
  • Sepsis


Dive into the research topics of 'Pancreatic Stone Protein: Review of a New Biomarker in Sepsis'. Together they form a unique fingerprint.

Cite this